- 4.4Impact Factor
- 8.8CiteScore
- 21 daysTime to First Decision
Special Issues
Cancers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Epstein-Barr Virus-Associated Cancers: From Pathogenesis to Treatment (2nd Edition)
Deadline: 31 July 2026
Recent Developments on PET-CT in Multiple Myeloma
Deadline: 31 July 2026
Pituitary Tumors: Clinical and Surgical Challenges
Deadline: 31 July 2026
The Emerging Role of Multiplexed Imaging for Cancer Diagnosis and Therapy (2nd Edition)
Deadline: 31 July 2026
Clinical Trials for Hepatobiliary and Pancreatic Cancer Diagnosis and Treatment (2nd Edition)
Deadline: 31 July 2026
Perioperative Care and Pain Management in Cancer Patients: From Basic Science to Clinical Practice—2nd Edition
Deadline: 31 July 2026
Mechanisms of Therapy Resistance in Cancers—2nd Edition
Deadline: 31 July 2026
Circulating Tumor Cells (CTCs) and the Implementation of Liquid Biopsy (2nd Edition)
Deadline: 31 July 2026
Hematopoietic Stem Cells and Cancer Immunotherapy
Deadline: 31 July 2026
Clinical Treatment and Prognosis of Breast Cancer
Deadline: 31 July 2026
Hybrid Molecular Imaging Approaches in Cancer: PET/CT, PET/MRI, and Beyond
Deadline: 31 July 2026
Tumorigenesis and Tumor Microenvironment—Insights and Interventions (TTMII)
Deadline: 31 July 2026
of 261

